Literature DB >> 28608188

[HIV-associated plasmablastic lymphoma of the paranasal sinuses : An incidental finding].

V Weber1, K Helling2, C Matthias2.   

Abstract

A 48-year-old female patient presented to the ENT department of the University Medical Center of the Johannes Gutenberg University Mainz with subfebrile temperatures, one-sided nasal obstruction, and left-sided cephalgia. Clinical examination and CT scans showed a mass occupying the left nasal cavity and left paranasal sinuses. Further diagnosis and histopathological examination showed an HIV-associated plasmablastic lymphoma of the left paranasal sinuses. This case report with literature review discusses the diagnosis and treatment of this rare nasal tumor.

Entities:  

Keywords:  Diagnosis and therapy; HIV; Lymphoma; Nasal obstruction; Paranasal sinus

Mesh：

Year:  2018        PMID： 28608188     DOI： 10.1007/s00106-017-0373-5

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


  11 in total

Review 1.  The biology and treatment of plasmablastic lymphoma.

Authors:  Jorge J Castillo; Michele Bibas; Roberto N Miranda
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

2.  Guidelines for NHL: updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia.

Authors:  Andrew D Zelenetz
Journal:  J Natl Compr Canc Netw       Date:  2014-05       Impact factor: 11.908

Review 3.  Overview of the oral HIV/AIDS Research Alliance Program.

Authors:  C H Shiboski; J Y Webster-Cyriaque; M Ghannoum; J S Greenspan; D Dittmer
Journal:  Adv Dent Res       Date:  2011-04

4.  Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.

Authors:  Sunita D Nasta; George M Carrum; Imran Shahab; Nicola A Hanania; Mark M Udden
Journal:  Leuk Lymphoma       Date:  2002-02

5.  Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.

Authors:  Camille Laurent; Bettina Fabiani; Catherine Do; Emmanuelle Tchernonog; Guillaume Cartron; Pauline Gravelle; Nadia Amara; Sandrine Malot; Maryknoll Mawanay Palisoc; Christiane Copie-Bergman; Alexandra Traverse Glehen; Marie-Christine Copin; Pierre Brousset; Stefania Pittaluga; Elaine S Jaffe; Paul Coppo
Journal:  Haematologica       Date:  2016-05-12       Impact factor: 9.941

6.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.

Authors:  H J Delecluse; I Anagnostopoulos; F Dallenbach; M Hummel; T Marafioti; U Schneider; D Huhn; A Schmidt-Westhausen; P A Reichart; U Gross; H Stein
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

7.  Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.

Authors:  Jorge J Castillo; Michael Furman; Brady E Beltrán; Michele Bibas; Mark Bower; Weina Chen; José L Díez-Martín; Jane J Liu; Roberto N Miranda; Silvia Montoto; Nahid M Nanaji; José-Tomás Navarro; Adam C Seegmiller; Julie M Vose
Journal:  Cancer       Date:  2012-04-17       Impact factor: 6.860

8.  Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.

Authors:  Julie Morscio; Daan Dierickx; Jan Nijs; Gregor Verhoef; Emilie Bittoun; Xanne Vanoeteren; Iwona Wlodarska; Xavier Sagaert; Thomas Tousseyn
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

9.  Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.

Authors:  Lluís Colomo; Florence Loong; Susana Rives; Stefania Pittaluga; Antonio Martínez; Armando López-Guillermo; Jesús Ojanguren; Vicens Romagosa; Elaine S Jaffe; Elías Campo
Journal:  Am J Surg Pathol       Date:  2004-06       Impact factor: 6.394

10.  Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.

Authors:  Sanam Loghavi; Khaled Alayed; Tariq N Aladily; Zhuang Zuo; Siok-Bian Ng; Guilin Tang; Shimin Hu; C Cameron Yin; Roberto N Miranda; L Jeffrey Medeiros; Joseph D Khoury
Journal:  J Hematol Oncol       Date:  2015-06-10       Impact factor: 17.388
View more
  1 in total

Review 1.  Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.

Authors:  Hirotaka Mori; Masahiko Fukatsu; Hiroshi Ohkawara; Yuka Oka; Yuki Kataoka; Shunsuke Taito; Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2021-08-30       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.